NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘pharmaceuticals’

6 February 2015

Hercules, Capital Ten, lift heart disease researcher to $23.3m Series B

untitled-1238683-m Hercules Bioventure Partners and Capital Ten have led a $23.3m Series B round for cardiovascular drugs company Armetheon.

27 January 2015

Chinese venture firm Legend Capital leads $100m round for Innovent Biologics

china-flag-1421043-m Beijing-headquartered Legend Capital has led a $100 m Series C financing round for Chinese pharmaceuticals group Innovent Biologics. Singapore-based investment company Temasek, with S$223bn ($178 bn) in AUM also took part in the round said Innovent. PE firms already invested in Innovent include Fidelity Biosciences, Fidelity Growth Partners Asia, Lilly Asia Ventures, and Frontline Bioventures.[...]

13 January 2015

Qualcomm Ventures forms $100m investment partnership with Novartis

syringe-974378-m Qualcomm Ventures, the venture capital arm of Qualcomm Incorporated, has partnered with Novartis Pharmaceuticals to target early stage companies in the healthcare tech sector.

30 October 2014

Warburg Pincus buys stake in India pharmaceutical Laurus Labs for $90m

download (1) Global private equity firm Warburg Pincus has invested INR5.5bn (around $90m) for a stake in Laurus Labs Private Limited, an Indian developer and manufacturer of Active Pharmaceutical Ingredients.

2 October 2014

Venture capital-backed Alios BioPharma sold to Johnson & Johnson for $1.75bn

sale-1306463-m Clinical stage biopharmaceutical company Alios BioPharma has been bought by multinational healthcare business Johnson & Johnson for around $1.75bn in cash.

15 September 2014

EIF investment helps NeoMed close Fund V on €92.1m

medical-care-962546-m Medical-focused venture capital firm NeoMed Management has held the final close of its Innovation V fund on €92.1m ($122m).

9 September 2014

Flex Pharma secures $40m in Bessemer-backed round

flex Biopharmaceutical company Flex Pharma, which is focused on developing treatments for neuromuscular disorders, has raised $40m from a number of investors including Bessemer Venture Partners.

4 September 2014

Swander Pace exits OTC healthcare company to trade partner in $750m deal

download (11) Private equity firm Swander Pace Capital has agreed to sell over-the-counter products company Insight Pharmaceuticals to strategic investor Prestige Brands Holdings for $750m.

1 September 2014

Qiming leads $30m for drug developer Zai Lab

china Chinese drug development company Zai Lab has secured $30m in a Series A round led by Qiming Venture Partners.

29 August 2014

Venture capital-backed Rhythm files for Nasdaq IPO

nasdaq Venture capital-backed metabolic drug developer Rhythm has filed for an IPO on the Nasdaq exchange.

Page 1 of 712345...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015